Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world
Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
COVID-19 and mucormycosis superinfection: the perfect storm
JA Al-Tawfiq, S Alhumaid, AN Alshukairi, MH Temsah… - Infection, 2021 - Springer
Background The recent emergence of the Coronavirus Disease (COVID-19) disease had
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
Invasive fungal infections complicating COVID-19: a narrative review
G Casalini, A Giacomelli, A Ridolfo, C Gervasoni… - Journal of Fungi, 2021 - mdpi.com
Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …
associated with a significant increase in mortality, especially in critically ill patients admitted …
Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review
A Bhattacharyya, P Sarma, DJ Sharma… - Indian journal of …, 2021 - journals.lww.com
Since the onset of COVID-19 pandemic, parallel opportunistic infections have also been
emerging as another disease spectrum. Among all these opportunistic infection …
emerging as another disease spectrum. Among all these opportunistic infection …
Overview on the prevalence of fungal infections, immune response, and microbiome role in COVID-19 patients
M Roudbary, S Kumar, A Kumar, L Černáková… - Journal of Fungi, 2021 - mdpi.com
Patients with severe COVID-19, such as individuals in intensive care units (ICU), are
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …
[HTML][HTML] Mucormycosis in COVID-19: A systematic review of literature
S Nagalli, NS Kikkeri - Le infezioni in medicina, 2021 - ncbi.nlm.nih.gov
SUMMARY Coronavirus disease 2019 (COVID-19) is an acute viral illness caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Opportunistic infections …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Opportunistic infections …
Clinical features and mortality of COVID-19-associated mucormycosis: a systematic review and meta-analysis
The recent increase of COVID-19-associated mucormycosis (CAM) has been commanding
global attention. However, basic epidemiologic characteristics have not firmly been …
global attention. However, basic epidemiologic characteristics have not firmly been …
COVID-19 associated mucormycosis: a systematic review from diagnostic challenges to management
The coronavirus disease 2019 (COVID-19) outbreak has caused significant destruction,
claiming over three million lives worldwide. Post SARS-COV-2 invasion …
claiming over three million lives worldwide. Post SARS-COV-2 invasion …
COVID-19-associated mucormycosis (CAM): case-series and global analysis of mortality risk factors
Background: Since the novel coronavirus disease (COVID-19) outbreak, the cases of COVID-
19 co-infections have been increasingly reported worldwide. Mucormycosis, an …
19 co-infections have been increasingly reported worldwide. Mucormycosis, an …
Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals
D Seidel, M Simon, R Sprute, M Lubnow, K Evert… - Mycoses, 2022 - Wiley Online Library
Background Most COVID‐19‐associated mucormycosis (CAM) cases are reported from
India and neighbouring countries. Anecdotally cases from Europe have been presented …
India and neighbouring countries. Anecdotally cases from Europe have been presented …